Synthesis, antiproliferative and apoptotic activities of N-(6(4)-indazolyl)-benzenesulfonamide derivatives as potential anticancer agents.

[1]  Hafid Zouihri,et al.  N-[7-Ethoxy-2-(prop-2-en-1-yl)-2H-indazol-6-yl]-4-methylbenzenesulfonamide , 2011, Acta crystallographica. Section E, Structure reports online.

[2]  Hafid Zouihri,et al.  N-[7-Ethoxy-1-(prop-2-en-1-yl)-1H-indazol-4-yl]-4-methylbenzenesulfonamide , 2011, Acta crystallographica. Section E, Structure reports online.

[3]  B. Narasimhan,et al.  Indazole: a medicinally important heterocyclic moiety , 2011, Medicinal Chemistry Research.

[4]  E. Essassi,et al.  Alkylation and reduction of N-alkyl-4-nitroindazoles with anhydrous SnCl2 in ethanol: synthesis of novel 7-ethoxy-N-alkylindazole derivatives , 2011 .

[5]  E. Essassi,et al.  Studies on the Reduction of the Nitro Group in 4-Nitroindazoles by Anhydrous SnCl2 in Different Alcohols , 2011 .

[6]  J. Pollard,et al.  Discovery and development of aurora kinase inhibitors as anticancer agents. , 2009, Journal of medicinal chemistry.

[7]  A. Gómez-Barrio,et al.  Synthesis and Evaluation of 1,1′‐Hydrocarbylenebis(indazol‐3‐ols) as Potential Antimalarial Drugs , 2009, ChemMedChem.

[8]  F. Meneghetti,et al.  Synthesis and antiproliferative activity of 3-amino-N-phenyl-1H-indazole-1-carboxamides. , 2009, European journal of medicinal chemistry.

[9]  D. Spinelli,et al.  Synthesis, in vitro activity and in vivo toxicity of the new 2,3-dinitrobutadiene derivative (1E,3E)-1,4-bis(2-naphthyl)-2,3-dinitro-1,3-butadiene. , 2007, Pharmacological research.

[10]  B. Sridhar,et al.  Synthesis and structure-activity relationships of novel pyrimido[1,2-b]indazoles as potential anticancer agents against A-549 cell lines. , 2007, Bioorganic & medicinal chemistry letters.

[11]  K. Glaser,et al.  Discovery of N-(4-(3-amino-1H-indazol-4-yl)phenyl)-N'-(2-fluoro-5-methylphenyl)urea (ABT-869), a 3-aminoindazole-based orally active multitargeted receptor tyrosine kinase inhibitor. , 2007, Journal of medicinal chemistry.

[12]  B. Pfeiffer,et al.  Synthesis and biological evaluation of N-(7-indazolyl)benzenesulfonamide derivatives as potent cell cycle inhibitors. , 2006, Bioorganic & medicinal chemistry.

[13]  S. Kuo,et al.  Synthesis of N2-(substituted benzyl)-3-(4-methylphenyl)indazoles as novel anti-angiogenic agents. , 2006, Bioorganic & medicinal chemistry.

[14]  V. Arán,et al.  ESR and electrochemical study of 5-nitroindazole derivatives with antiprotozoal activity. , 2006, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.

[15]  V. Arán,et al.  Pharmacological properties of indazole derivatives: recent developments. , 2005, Mini reviews in medicinal chemistry.

[16]  D. Spinelli,et al.  Inhibition of cell proliferation, cytotoxicity and induction of apoptosis of 1,4-bis(1-naphthyl)-2,3-dinitro-1,3-butadiene in gastrointestinal tumour cell lines and preliminary evaluation of its toxicity in vivo. , 2005, Pharmacological research.

[17]  J. Leger,et al.  New and efficient synthesis of bi- and trisubstituted indazoles , 2005 .

[18]  M. Jakupec,et al.  Redox-active antineoplastic ruthenium complexes with indazole: correlation of in vitro potency and reduction potential. , 2005, Journal of medicinal chemistry.

[19]  Patrick A. Curmi,et al.  Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain , 2004, Nature.

[20]  H. Parnes,et al.  Phase I trial of chloroguinoxaline sulfonamide, with correlation of its pharmacokinetics and pharmacodynamics , 2004, Cancer Chemotherapy and Pharmacology.

[21]  K. Appelt,et al.  Structure-based design, synthesis, and antimicrobial activity of indazole-derived SAH/MTA nucleosidase inhibitors. , 2003, Journal of medicinal chemistry.

[22]  S. Caron,et al.  The Synthesis of a Selective PDE4/TNFα Inhibitor , 2001 .

[23]  T. Owa,et al.  Novel sulphonamide derivatives for the treatment of cancer , 2000 .

[24]  Ralf Krahe,et al.  The γ-tubulin gene family in humans , 2000 .

[25]  J. Rodgers,et al.  Efficient Synthesis of 5-(Bromomethyl)- and 5-(Aminomethyl)-1-THP-Indazole , 1997 .

[26]  A. Yamaguchi,et al.  Mechanism of action of E7010, an orally active sulfonamide antitumor agent: inhibition of mitosis by binding to the colchicine site of tubulin. , 1997, Cancer research.

[27]  A. Nouri,et al.  A new approach for measurement of cytotoxicity using colorimetric assay. , 1993, Journal of immunological methods.

[28]  R. W. Harper,et al.  Novel agents effective against solid tumors: the diarylsulfonylureas. Synthesis, activities, and analysis of quantitative structure-activity relationships. , 1990, Journal of medicinal chemistry.